Posted on
9 dicembre 2014
Hatzimichael E, Dasoula A, Lo Nigro C, Lattanzio L, Syed N, Merlano M, Bourantas K, Crook T: “Leprecan Like 1 (Leprel1) a prolyl-3-hydroxylase, but not Leprel2 or Leprecan, is a novel target for epigenetic silencing in multiple myeloma”. Lymphoma and Myeloma Meeting, NYC, USA, 21-23 ottobre 201